TABLE 1.
Protein | Antibiotic
|
Substrate analogue S2d kcat/Km (M−1 s−1)a | Source or reference | ||
---|---|---|---|---|---|
Cefotaxime k2/K (M−1 s−1) | Benzylpenicillin k2/K (M−1 s−1) | Benzylpenicillin k3 (s−1) [half-life time; h] | |||
PBP 2a* | 7,700 (±600)b | <3,800 | 3.2 × 10−5 [6] | 220 (±20)b | This study |
PBP 1a* | 11,933 | 34,200 | 1.0 × 10−5 [14] | 256 | 3 |
S-PBP 2x* | 209,000 | 99,000 | 3.5 × 10−5 [5.8] | 2,500 | 18 |
R-PBP 2x* | 3,300 | <3,800 | 4.2 × 10−5 [4.6] | 20 | 18 |
The kcat/Km value of PBP 1a* for S2d reported in this table takes into account the racemic nature of S2d (twofold increase) compared to the value reported in reference 3
The standard deviation was determined from totally independent measurements.